Mallinckrodt Pharmaceuticals
MNK
#10200
Rank
C$6.26 M
Marketcap
$0.47
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

EPS for Mallinckrodt Pharmaceuticals (MNK)

EPS in 2023 (TTM): -$162.67

According to Mallinckrodt Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$167.74. In 2021 the company made an earnings per share (EPS) of -$11.73 an increase over its 2020 EPS that were of -$15.50.

EPS history for Mallinckrodt Pharmaceuticals from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$162.67
2021-$11.73-24.31%
2020-$15.50-5.41%
2019-$16.39-72.67%
2018-$59.97-291.46%
2017$31.32797.22%
2016$3.49-34.03%
2015$5.29-207.61%
2014-$4.92-366.73%
2013$1.84

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$19.51-111.63%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.77-98.35%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
$11.85-107.06%๐Ÿ‡บ๐Ÿ‡ธ USA